BACKGROUND: Circulating endothelial progenitor cells (EPCs) are recruited from the blood system to sites of ischemia and endothelial damage, where they contribute to the repair and development of blood vessels. Since numerous eicosanoids including leukotrienes (LTs) and hydroxyeicosatetraenoic acids (HETEs) have been shown to exert potent pro-inflammatory activities, we examined their levels in chronic diabetic patients with severe cardiac ischemia in conjunction with the level and function of EPCs. RESULTS: Lipidomic analysis revealed a diabetes-specific increase (p<0.05) in inflammatory and angiogenic eicosanoids including the 5-lipoxygenase-derived LTB (4.11±1.17 vs. 0.96±0.27 ng/ml), the lipoxygenase/CYP-derived 12-HETE (117.08±35.05 vs. 24.34±10.03 ng/ml), 12-HETrE (17.56±4.43 vs. 4.15±2.07 ng/ml), and the CYP-derived 20-HETE (0.32±0.04 vs. 0.06±0.05 ng/ml) the level of which correlated with BMI (p=0.0027). In contrast, levels of the CYP-derived EETs were not significantly (p=0.36) different between these two groups. EPC levels and their colony-forming units were lower (p<0.05) with a reduced viability in diabetic patients compared with non-diabetics. EPC function (colony-forming units (CFUs) and MTT assay) also negatively correlated with the circulating levels of HgA1C. CONCLUSION: This study demonstrates a close association between elevated levels of highly pro-inflammatory eicosonoids, diabetes and EPC dysfunction in patients with cardiac ischemia, indicating that chronic inflammation impact negatively on EPC function and angiogenic capacity in diabetes.
BACKGROUND: Circulating endothelial progenitor cells (EPCs) are recruited from the blood system to sites of ischemia and endothelial damage, where they contribute to the repair and development of blood vessels. Since numerous eicosanoids including leukotrienes (LTs) and hydroxyeicosatetraenoic acids (HETEs) have been shown to exert potent pro-inflammatory activities, we examined their levels in chronic diabeticpatients with severe cardiac ischemia in conjunction with the level and function of EPCs. RESULTS: Lipidomic analysis revealed a diabetes-specific increase (p<0.05) in inflammatory and angiogenic eicosanoids including the 5-lipoxygenase-derived LTB (4.11±1.17 vs. 0.96±0.27 ng/ml), the lipoxygenase/CYP-derived 12-HETE (117.08±35.05 vs. 24.34±10.03 ng/ml), 12-HETrE (17.56±4.43 vs. 4.15±2.07 ng/ml), and the CYP-derived 20-HETE (0.32±0.04 vs. 0.06±0.05 ng/ml) the level of which correlated with BMI (p=0.0027). In contrast, levels of the CYP-derived EETs were not significantly (p=0.36) different between these two groups. EPC levels and their colony-forming units were lower (p<0.05) with a reduced viability in diabeticpatients compared with non-diabetics. EPC function (colony-forming units (CFUs) and MTT assay) also negatively correlated with the circulating levels of HgA1C. CONCLUSION: This study demonstrates a close association between elevated levels of highly pro-inflammatory eicosonoids, diabetes and EPC dysfunction in patients with cardiac ischemia, indicating that chronic inflammation impact negatively on EPC function and angiogenic capacity in diabetes.
Authors: Oren M Tepper; Robert D Galiano; Jennifer M Capla; Christoph Kalka; Paul J Gagne; Glen R Jacobowitz; Jamie P Levine; Geoffrey C Gurtner Journal: Circulation Date: 2002-11-26 Impact factor: 29.690
Authors: Subodh Verma; Michael A Kuliszewski; Shu-Hong Li; Paul E Szmitko; Liana Zucco; Chao-Hung Wang; Mitesh V Badiwala; Donald A G Mickle; Richard D Weisel; Paul W M Fedak; Duncan J Stewart; Michael J B Kutryk Journal: Circulation Date: 2004-04-12 Impact factor: 29.690
Authors: Stephen J Peterson; Joseph I Shapiro; Ellen Thompson; Shailendra Singh; Lu Liu; Jeremy A Weingarten; Kathleen O'Hanlon; Angelica Bialczak; Siddharth R Bhesania; Nader G Abraham Journal: Obesity (Silver Spring) Date: 2019-01 Impact factor: 5.002
Authors: Samantha L Hoopes; Victor Garcia; Matthew L Edin; Michal L Schwartzman; Darryl C Zeldin Journal: Prostaglandins Other Lipid Mediat Date: 2015-03-23 Impact factor: 3.072
Authors: Victor Garcia; Ankit Gilani; Brian Shkolnik; Varunkumar Pandey; Frank Fan Zhang; Rambabu Dakarapu; Shyam K Gandham; N Rami Reddy; Joan P Graves; Artiom Gruzdev; Darryl C Zeldin; Jorge H Capdevila; John R Falck; Michal Laniado Schwartzman Journal: Circ Res Date: 2017-03-21 Impact factor: 17.367
Authors: Aleksandar Kibel; Kristina Selthofer-Relatic; Ines Drenjancevic; Tatjana Bacun; Ivica Bosnjak; Dijana Kibel; Mario Gros Journal: J Int Med Res Date: 2017-01-12 Impact factor: 1.671
Authors: Ankit Gilani; Varunkumar Pandey; Victor Garcia; Kevin Agostinucci; Shailendra P Singh; Joseph Schragenheim; Lars Bellner; John R Falck; Mahesh P Paudyal; Jorge H Capdevila; Nader G Abraham; Michal Laniado Schwartzman Journal: Am J Physiol Regul Integr Comp Physiol Date: 2018-08-08 Impact factor: 3.619
Authors: Alexander J Nelson; Daniel J Stephenson; Christopher L Cardona; Xiaoyong Lei; Abdulaziz Almutairi; Tayleur D White; Ying G Tusing; Margaret A Park; Suzanne E Barbour; Charles E Chalfant; Sasanka Ramanadham Journal: J Lipid Res Date: 2019-12-09 Impact factor: 5.922
Authors: Ankit Gilani; Kevin Agostinucci; Sakib Hossain; Jonathan V Pascale; Victor Garcia; Adeniyi Michael Adebesin; John R Falck; Michal Laniado Schwartzman Journal: Prostaglandins Other Lipid Mediat Date: 2020-10-01 Impact factor: 3.072